SE stock is rated Hold due to valuation constraints and pipeline setbacks, despite strong commercial execution with VYVGART. Click here for more on ARGX.

BioCardia’s data safety monitoring board already warned that the phase 3 CardiAMP cell therapy heart failure trial was not going to make the primary endpoint. And so the California biotech is ...

Bayer’s Kerendia, already FDA approved in one cardiometabolic indication, now has data from a pivotal test that support expanding the drug’s label to heart failure. In preliminary results reported ...

A phase 3 trial for dapagliflozin finds that the SGLT2 inhibitor is effective in reducing the risk of cardiovascular death and worsening heart failure in patients with preserved ejection fraction.

A phase 3 trial of Bayer and Merck’s vericiguat in heart failure patients has met its primary endpoint. The top-line readout appears to justify the risk the partners took when they moved the ...

Cassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trial, causing the stock to plummet ~90% and trade near book value. The company's decision to discontinue other simufilam trials signals ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting neurological diseases. Some failures split up partners, and one particularly ...

Secretary of State Mike Pompeo recently suggested the United States should approach China with a “distrust and verify” mindset. If the Secretary speaks for President Trump, the “phase one” trade deal ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, ...

HANOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced ...

According to preliminary results announced Thursday, the BMS drug did not beat a placebo measured against the study’s main goal of showing clinical remission in ulcerative colitis, an inflammatory ...

Climate advocates are warning the COP28 climate summit could be on the cusp of failure after a new draft of the core agreement removed a call to phase out fossil fuels, the main driver of the climate ...